Skip to content

G1 THERAPEUTICS, INC.

CIK 0001560241

← back to feed
Revenue (TTM)
$85.71M
+705.0% YoY Q2 Aug 2024
Net Income (TTM)
−$25.18M
−42.6% YoY Q2 Aug 2024
EPS Diluted (TTM)
−$0.51
−27.4% YoY Q2 Aug 2024
Gross Margin
—
Q2 Aug 2024
Operating Margin
-20.3%
Q2 Aug 2024
Net Margin
-29.4%
Q2 Aug 2024
Free Cash Flow (TTM)
−$103.02M
Q2 Aug 2024
Cash
$15.07M
Q2 Aug 2024
Total Debt
$44.32M
Q2 Aug 2024
Shares Outstanding
52.76M sh
Q2 Aug 2024

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings